CO2-Based Shunt Estimation for Non-Invasive Pulmonary Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring shunt in critically ill patients are invasive, costly, and provide unreliable estimates, often failing to accurately assess pulmonary function, especially in mechanically ventilated patients.
Innovation Solution
A minimally invasive method using carbon dioxide measurements from exhaled gas to estimate shunt, based on a modified Berggren equation and the Fick principle, eliminating the need for invasive venous blood samples and incorporating cardiac output or effective pulmonary perfusion calculations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If pulmonary artery catheter (PAC) is used to measure shunt, then measurement precision is improved, but device complexity and invasiveness increase significantly
Solution Approach 1:
The patent uses carbon dioxide as an intermediary substance to indirectly measure shunt. Instead of directly measuring oxygen content in blood samples (which requires invasive PAC), the method measures CO2 in expired gas, which correlates with shunt fraction. This intermediary approach maintains measurement accuracy while eliminating the need for invasive catheterization.
Solution Approach 2:
The patent replaces the mechanical/invasive PAC system with a non-invasive gas analysis system. By substituting the physical intrusion of catheters with optical/chemical detection of CO2 in expired breath, the method achieves the same measurement function without the harmful mechanical intervention.
2Measurement precision
If pulmonary artery catheter (PAC) is used for shunt measurement, then shunt determination is improved, but object-affected harmful factors increase due to severe complications
Solution Approach 1:
The patent converts the naturally present CO2 in expired gas (which would otherwise be a waste product) into a useful measurement signal. By utilizing this readily available biological byproduct, the method transforms a harmless natural phenomenon into a diagnostic tool that avoids the harmful effects of invasive procedures.
Solution Approach 2:
The patient's own respiratory system provides the measurement signal. The CO2 in expired breath is naturally produced by the patient's metabolism and exhalation, requiring no external intervention, injected substances, or invasive access. The body essentially measures itself through its normal physiological function.
3Reliability
If traditional shunt measurement methods are used, then comprehensive lung function assessment is improved, but ease of operation deteriorates due to invasive procedures
Solution Approach 1:
The patent creates a functional copy of the invasive measurement process using non-invasive means. By measuring CO2 in expired gas and calculating shunt fraction through mathematical relationships, the method replicates the information obtained from invasive blood sampling without requiring actual blood draws or catheterization.
4Measurement precision
If multiple invasive measurements are performed for shunt calculation, then measurement precision is improved, but loss of time increases due to complex sampling procedures
Solution Approach 1:
The patent enables continuous monitoring of shunt fraction by continuously analyzing CO2 in expired gas. Unlike discrete blood sampling that occurs at specific time points, the gas analysis method can continuously track changes in shunt, providing ongoing information without repeated interruptions for sampling procedures.
Data Source
Figure 1A~2
Figure 3A~3C
Figure 4
AI summary
The present invention presents a CO2-based method for estimating shunt of a subject. The method comprises the steps of: obtaining (S2), from CO2 measurements on expiration gas exhaled by said subject, a first value related to alveolar CO2 of said subject; obtaining (S3) a second value related to arterial CO2 of said subject; obtaining (S4) a third value related to cardiac output [QT] or effective pulmonary perfusion [EPP] of said subject;obtaining (S5) a fourth value related to CO2 elimination [VCO2] of said subject, and;calculating (S6) the shunt of the subject based on said first, second, third and fourth values. The method allows the shunt of the subject to be determined in a non-invasive or minimally-invasive way without requiring determination of the venous or capillary CO2 contents of the subject, which in turn allows the method to be carried out at the bedside, enabling reliable monitoring of shunt in clinical practice.